This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignee: Cell Signaling Technology, Inc.. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2026
Title: Innovations of Inventor Jing Li
Introduction
Jing Li is a prominent inventor based in Brighton, MA (US), known for his significant contributions to the field of biotechnology. With a total of four patents to his name, he has made remarkable advancements in the development of antibodies that have broad applications in proteomic analysis.
Latest Patents
One of Jing Li's latest patents involves the creation of motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residue. This innovative antibody targets a recurring modified motif, which includes at least one sumoylated lysine residue and one or more degenerate amino acids. The antibody is designed to bind this motif across a variety of non-homologous peptides or proteins within an organism. Another significant patent focuses on the analysis of ubiquitinated polypeptides. This disclosure relates to antibody reagents that specifically bind to peptides carrying a ubiquitin remnant, allowing for the identification of ubiquitinated polypeptides and the sites of ubiquitination. These reagents are particularly useful in proteomic analysis using mass spectrometry, as their affinity to the ubiquitin remnant is context-independent.
Career Highlights
Jing Li is currently employed at Cell Signaling Technology, Inc., where he continues to innovate and develop new technologies in the field of antibody research. His work has been instrumental in advancing the understanding of protein modifications and their implications in various biological processes.
Collaborations
Some of Jing Li's notable coworkers include John Edward Rush, II and Ailan Guo, who contribute to the collaborative efforts in research and development within their organization.
Conclusion
Jing Li's innovative work in antibody development and proteomic analysis showcases his significant impact on biotechnology. His contributions continue to enhance the understanding of protein interactions and modifications, paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile